Related Experiment Videos

Anti-neuroinflammatory effects of the extract of Achillea fragrantissima

Anat Elmann1, Sharon Mordechay, Hilla Erlank

  • 1Department of Food Quality and Safety, Volcani Center, Agricultural Research Organization, Bet Dagan 50250, Israel. aelmann@volcani.agri.gov.il

Abstract

Insights

The extract of Achillea fragrantissima (Af) significantly reduced nitric oxide (NO) production in activated microglial cells. This desert plant extract also inhibited key inflammatory mediators, showing potential for neurodegenerative disease treatment.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Immunology

Background:

  • Neuroinflammation, driven by activated microglial cells, is central to neurodegenerative diseases like Parkinson's and Alzheimer's.
  • Activated microglia release pro-inflammatory mediators, including nitric oxide (NO), cytokines, and matrix metalloproteinases (MMPs).
  • Traditional medicine often utilizes desert plants for therapeutic purposes, necessitating scientific validation.

Purpose of the Study:

  • To investigate the anti-neuroinflammatory effects of extracts from 66 desert plants on lipopolysaccharide (LPS)-activated microglial cells.
  • To identify specific plant extracts that can inhibit the production of pro-inflammatory mediators.
  • To evaluate the efficacy of Achillea fragrantissima (Af) extract in mitigating neuroinflammation.

Main Methods:

  • Screening of 66 desert plant extracts for their ability to inhibit LPS-induced NO production in primary microglial cells.
  • Detailed analysis of the most potent extract (Af) for its effects on cytokines (IL-1β, TNFα), NO, reactive oxygen species (ROS), MMP-9 activity, and protein levels of COX-2 and iNOS.
  • Assessment of cell viability using lactate dehydrogenase (LDH) activity and crystal violet staining.

Main Results:

  • Achillea fragrantissima (Af) extract demonstrated the highest efficacy, inhibiting approximately 70% of LPS-induced NO production without compromising cell viability.
  • The Af extract significantly suppressed the expression of pro-inflammatory cytokines (IL-1β, TNFα), MMP-9, COX-2, and iNOS.
  • These findings highlight the potent anti-neuroinflammatory properties of the Af extract.

Conclusions:

  • Phytochemicals within the Achillea fragrantissima (Af) extract possess significant anti-neuroinflammatory potential.
  • The Af extract may serve as a valuable therapeutic agent for preventing or treating neurodegenerative diseases characterized by neuroinflammation.
  • Further research into Af's active compounds could lead to novel drug development for neurological disorders.

Related Concept Videos

Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Cholinergic Antagonists: Therapeutic Uses01:26

Cholinergic Antagonists: Therapeutic Uses

Antimuscarinic drugs have various therapeutic applications by inhibiting parasympathetic stimulation in different systems. Here are the key therapeutic uses of antimuscarinics:    
Respiratory Tract: Ipratropium, aclidinium, and tiotropium treat asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). They protect against bronchoconstriction caused by irritants like cigarette smoke, sulfur dioxide, and ozone. They also help reduce nasopharyngeal secretions in common...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Direct-Acting Cholinergic Agonists: Therapeutic Uses01:11

Direct-Acting Cholinergic Agonists: Therapeutic Uses

Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren syndrome.
Drugs Affecting Neurotransmitter Release or Uptake01:21

Drugs Affecting Neurotransmitter Release or Uptake

Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...